Juerg Schwitter

Juerg Schwitter

Auto-generated profile, based on publicly available information

Juerg Schwitter

Service of Cardiology Lausanne University Hospital (CHUV) and University of Lausanne (UNIL) Lausanne Switzerland

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2012 in European Heart Journal
Verified
Journal Article
Open access
PDF file
JSJuerg Schwitter
Juerg Schwitter
CWChristian M. Wacker
Christian M. Wacker
NWNorbert Wilke
Norbert Wilke
NANidal Al-Saadi
Nidal Al-Saadi
ESEkkehart Sauer
Ekkehart Sauer
FIfor the MR-IMPACT Investigators
for the MR-IMPACT Investigators
Perfusion-cardiac magnetic resonance (CMR) has emerged as a potential alternative to single-photon emission computed tomography (SPECT) to assess myocardial ischaemia non-invasively. The goal was to compare the diagnostic performance of perfusion-CMR and SPECT for the detection of coronary artery disease (CAD) using conventional X-ray coronary angiography (CXA) as the reference standard. In this multivendor trial, 533 patients, eligible for CXA or SPECT, were enrolled in 33 centres (USA and Europe) with 515 patients receiving MR contrast medium. Single-photon emission computed tomography and CXA were performed within 4 weeks before or after CMR in all patients. The prevalence of CAD in the sample was 49%. Drop-out rates for CMR and SPECT were 5.6 and 3.7%, respectively (P = 0.21). The primary endpoint was non-inferiority of CMR vs. SPECT for both sensitivity and specificity for the detection of CAD. Readers were blinded vs. clinical data, CXA, and imaging results. As a secondary endpoint, the safety profile of the CMR examination was evaluated. For CMR and SPECT, the sensitivity scores were 0.67 and 0.59, respectively, with the lower confidence level for the difference of +0.02, indicating superiority of CMR over SPECT. The specificity scores for CMR and SPECT were 0.61 and 0.72, respectively (lower confidence level for the difference: −0.17), indicating inferiority of CMR vs. SPECT. No severe adverse events occurred in the 515 patients. In this large multicentre, multivendor study, the sensitivity of perfusion-CMR to detect CAD was superior to SPECT, while its specificity was inferior to SPECT. Cardiac magnetic resonance is a safe alternative to SPECT to detect perfusion deficits in CAD.

1 January 2013 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
OBOliver Bruder
Oliver Bruder
AWAnja Wagner
Anja Wagner
MLMassimo Lombardi
Massimo Lombardi
JSJürg Schwitter
Jürg Schwitter
ARAlbert van Rossum
Albert van Rossum
HMHeiko Mahrholdt
Heiko Mahrholdt
The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR.

1 September 2014 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
GVGabriella Vincenti
Gabriella Vincenti
PMPierre Monney
Pierre Monney
JCJérôme Chaptinel
Jérôme Chaptinel
TRTobias Rutz
Tobias Rutz
SCSimone Coppo
Simone Coppo
JSJuerg Schwitter
Juerg Schwitter

1 January 2012 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
JSJuerg Schwitter
Juerg Schwitter
CWChristian M Wacker
Christian M Wacker
NWNorbert Wilke
Norbert Wilke
NANidal Al-Saadi
Nidal Al-Saadi
ESEkkehart Sauer
Ekkehart Sauer
TSTamas Simor
Tamas Simor
Perfusion-cardiovascular magnetic resonance (CMR) is generally accepted as an alternative to SPECT to assess myocardial ischemia non-invasively. However its performance vs gated-SPECT and in sub-populations is not fully established. The goal was to compare in a multicenter setting the diagnostic performance of perfusion-CMR and gated-SPECT for the detection of CAD in various populations using conventional x-ray coronary angiography (CXA) as the standard of reference.

1 May 2017 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
GVGabriella Vincenti
Gabriella Vincenti
PMPier Giorgio Masci
Pier Giorgio Masci
PMPierre Monney
Pierre Monney
TRTobias Rutz
Tobias Rutz
SHSarah Hugelshofer
Sarah Hugelshofer
JSJuerg Schwitter
Juerg Schwitter

1 January 2023 in Radiology
Verified
Journal Article
Closed access
SFStefano Figliozzi
Stefano Figliozzi
GGGeorgios Georgiopoulos
Georgios Georgiopoulos
PLPedro M. Lopes
Pedro M. Lopes
KBKlemens B. Bauer
Klemens B. Bauer
SMSara Moura-Ferreira
Sara Moura-Ferreira
PMPier-Giorgio Masci
Pier-Giorgio Masci
In mitral valve prolapse, myocardial fibrosis at cardiac MRI was associated with an increased risk of unexplained syncope, sustained ventricular tachycardia, or sudden cardiac death. Background Patients with mitral valve prolapse (MVP) may develop adverse outcomes even in the absence of mitral regurgitation or left ventricular (LV) dysfunction. Purpose To investigate the progno...